Sci Show: Children and young adults who receive CAR T-cell therapy for the most common childhood cancer, acute lymphoblastic leukemia, suffer remarkably fewer relapses and are far more likely to survive when the treatment is paired with a subsequent stem cell transplant, a new study finds

Saturday, April 3, 2021

Children and young adults who receive CAR T-cell therapy for the most common childhood cancer, acute lymphoblastic leukemia, suffer remarkably fewer relapses and are far more likely to survive when the treatment is paired with a subsequent stem cell transplant, a new study finds

https://ift.tt/3fvNeI3 via /r/science https://ift.tt/2Og5utA

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)